Trial intelligence / Profile preview

Colchicine peeling for premalignant forearm skin lesions

RBR-6bn7y6zPhase 2Completed

Sponsor
Sociedade Brasileira de Dermatologia Regional São Paulo
Start
Aug 2023
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in actinic keratosis (AK) comparing Jessner solution + colchicine 0.5% cream with Jessner solution + placebo cream (2 arms). Started Aug 2023; status: completed.

02

Drugs

colchicine
03

Conditions

actinic keratosis (AK)

Beyond the preview

Go deeper on RBR-6bn7y6z.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6bn7y6z.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call